
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Epigenetic and transcriptomic characterization reveals progression markers and essential pathways in clear cell renal cell carcinoma
Yige Wu, Nadezhda V. Terekhanova, Wagma Caravan, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 23
Yige Wu, Nadezhda V. Terekhanova, Wagma Caravan, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 23
Showing 23 citing articles:
Epigenetic regulation during cancer transitions across 11 tumour types
Nadezhda V. Terekhanova, Alla Karpova, Wen-Wei Liang, et al.
Nature (2023) Vol. 623, Iss. 7986, pp. 432-441
Open Access | Times Cited: 83
Nadezhda V. Terekhanova, Alla Karpova, Wen-Wei Liang, et al.
Nature (2023) Vol. 623, Iss. 7986, pp. 432-441
Open Access | Times Cited: 83
Tumour evolution and microenvironment interactions in 2D and 3D space
Chia-Kuei Mo, Jingxian Liu, Siqi Chen, et al.
Nature (2024) Vol. 634, Iss. 8036, pp. 1178-1186
Open Access | Times Cited: 23
Chia-Kuei Mo, Jingxian Liu, Siqi Chen, et al.
Nature (2024) Vol. 634, Iss. 8036, pp. 1178-1186
Open Access | Times Cited: 23
The chromatin landscape of healthy and injured cell types in the human kidney
Debora L. Gisch, Michelle Brennan, Blue B. Lake, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 18
Debora L. Gisch, Michelle Brennan, Blue B. Lake, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 18
A nanoparticle-based sonodynamic therapy reduces Helicobacter pylori infection in mouse without disrupting gut microbiota
Tao Liu, Shuang Chai, Mingyang Li, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 12
Tao Liu, Shuang Chai, Mingyang Li, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 12
Spatiotemporal multi-omics: exploring molecular landscapes in aging and regenerative medicine
Liuxi Chu, Wenjia Wang, Xin-Pei Gu, et al.
Military Medical Research (2024) Vol. 11, Iss. 1
Open Access | Times Cited: 5
Liuxi Chu, Wenjia Wang, Xin-Pei Gu, et al.
Military Medical Research (2024) Vol. 11, Iss. 1
Open Access | Times Cited: 5
Conserved patterns of transcriptional dysregulation, heterogeneity, and cell states in clear cell kidney cancer
Olivia Lombardi, Ran Li, Faiz Jabbar, et al.
Cell Reports (2025) Vol. 44, Iss. 1, pp. 115169-115169
Closed Access
Olivia Lombardi, Ran Li, Faiz Jabbar, et al.
Cell Reports (2025) Vol. 44, Iss. 1, pp. 115169-115169
Closed Access
Lessons learned from spatial transcriptomic analyses in clear-cell renal cell carcinoma
J. H. Jespersen, Cecilie Lindgaard, Laura Iisager, et al.
Nature Reviews Urology (2025)
Closed Access
J. H. Jespersen, Cecilie Lindgaard, Laura Iisager, et al.
Nature Reviews Urology (2025)
Closed Access
Molecular mechanisms of renal cell carcinoma metastasis and potential targets for therapy
Xinwei Li, Wei Xiong, Zhiyong Xiong, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access
Xinwei Li, Wei Xiong, Zhiyong Xiong, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access
Effect of FLRT3 on epithelial-mesenchymal transition in clear cell renal cell carcinoma
Jiongming Wang, Z. Xie, Shansen Peng, et al.
Urologia Journal (2025)
Closed Access
Jiongming Wang, Z. Xie, Shansen Peng, et al.
Urologia Journal (2025)
Closed Access
Silencing of genes by promoter hypermethylation shapes tumor microenvironment and resistance to immunotherapy in clear-cell renal cell carcinomas
Xiaofan Lu, Yann Vano, Xiaoping Su, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 11, pp. 101287-101287
Open Access | Times Cited: 10
Xiaofan Lu, Yann Vano, Xiaoping Su, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 11, pp. 101287-101287
Open Access | Times Cited: 10
Small extracellular vesicles from surviving cancer cells as multiparametric monitoring tools of measurable residual disease and therapeutic efficiency
Gábor Valcz, Edit I. Buzás, Robert A. Gatenby, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 2, pp. 189088-189088
Open Access | Times Cited: 3
Gábor Valcz, Edit I. Buzás, Robert A. Gatenby, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 2, pp. 189088-189088
Open Access | Times Cited: 3
Combining the Tyrosine Kinase Inhibitor Cabozantinib and the mTORC1/2 Inhibitor Sapanisertib Blocks ERK Pathway Activity and Suppresses Tumor Growth in Renal Cell Carcinoma
Yige Wu, Siqi Chen, Xiaolu Yang, et al.
Cancer Research (2023) Vol. 83, Iss. 24, pp. 4161-4178
Open Access | Times Cited: 8
Yige Wu, Siqi Chen, Xiaolu Yang, et al.
Cancer Research (2023) Vol. 83, Iss. 24, pp. 4161-4178
Open Access | Times Cited: 8
Genomic and epigenomic integrative subtypes of renal cell carcinoma in a Japanese cohort
Akihiko Fukagawa, Natsuko Hama, Yasushi Totoki, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 8
Akihiko Fukagawa, Natsuko Hama, Yasushi Totoki, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 8
Increased spatial coupling of integrin and collagen IV in the immunoresistant clear-cell renal-cell carcinoma tumor microenvironment
Alex C. Soupir, Mitchell Hayes, Taylor Peak, et al.
Genome biology (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 2
Alex C. Soupir, Mitchell Hayes, Taylor Peak, et al.
Genome biology (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 2
ZNF471 Interacts with BANP to Reduce Tumour Malignancy by Inactivating PI3K/AKT/mTOR Signalling but is Frequently Silenced by Aberrant Promoter Methylation in Renal Cell Carcinoma
Xiaofei Wang, Yao Lin, Zheng Li, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 2, pp. 643-663
Open Access | Times Cited: 2
Xiaofei Wang, Yao Lin, Zheng Li, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 2, pp. 643-663
Open Access | Times Cited: 2
Oncogenic cell tagging and single-cell transcriptomics reveal cell type-specific and time-resolved responses to Vhl inactivation in the kidney
Samvid Kurlekar, Joanna D.C.C. Lima, Ran Li, et al.
Cancer Research (2024) Vol. 84, Iss. 11, pp. 1799-1816
Open Access | Times Cited: 2
Samvid Kurlekar, Joanna D.C.C. Lima, Ran Li, et al.
Cancer Research (2024) Vol. 84, Iss. 11, pp. 1799-1816
Open Access | Times Cited: 2
Recent Advances in Single-Cell RNA-Sequencing of Primary and Metastatic Clear Cell Renal Cell Carcinoma
Adele M. Alchahin, Ioanna Tsea, Ninib Baryawno
Cancers (2023) Vol. 15, Iss. 19, pp. 4734-4734
Open Access | Times Cited: 6
Adele M. Alchahin, Ioanna Tsea, Ninib Baryawno
Cancers (2023) Vol. 15, Iss. 19, pp. 4734-4734
Open Access | Times Cited: 6
The chromatin landscape of healthy and injured cell types in the human kidney
Debora L. Gisch, Michelle Brennan, Blue B. Lake, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4
Debora L. Gisch, Michelle Brennan, Blue B. Lake, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4
Unveiling the hidden AP-1: revealing the crucial role of AP-1 in ccRCC at single-cell resolution
Jie Zheng, Fengling Liu, Cheng Su
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Jie Zheng, Fengling Liu, Cheng Su
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Biomarker identification and risk prediction model development for differentiated thyroid carcinoma lung metastasis based on primary lesion proteomics
Xiaoqi Peng, Hongbo Zhao, Lijuan Ye, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 14, pp. 3059-3072
Open Access
Xiaoqi Peng, Hongbo Zhao, Lijuan Ye, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 14, pp. 3059-3072
Open Access
Single-cell epigenetic profiling reveals an interferon response-high program associated withBAP1deficiency in kidney cancer
Sabrina Y. Camp, Meng Xiao He, Michael S. Cuoco, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Sabrina Y. Camp, Meng Xiao He, Michael S. Cuoco, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Disruption of the epigenetic regulator BAP1 drives chromatin remodeling leading to the emergence of cells with breast cancer stem cell properties and aberrant glycosylation.
Mariana Gomes da Silva Araujo, Aurèlie Sallé, Vincent Cahais, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Mariana Gomes da Silva Araujo, Aurèlie Sallé, Vincent Cahais, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Increased spatial coupling of integrin and collagen IV in the immunoresistant clear cell renal cell carcinoma tumor microenvironment
Alex C. Soupir, Mitchell Hayes, Taylor Peak, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Alex C. Soupir, Mitchell Hayes, Taylor Peak, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1